FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells

Biswajyoti Sahu1, Marko Laakso, Päivi Pihlajamaa

  • 1Institute of Biomedicine and Research Programs Unit, Genome-Scale Biology, Biomedicum Helsinki, University of Helsinki, Finland.

Cancer Research
|December 28, 2012
PubMed

Insights

Forkhead protein FoxA1 influences androgen receptor (AR) and glucocorticoid receptor (GR) binding sites, revealing cell-type specificity. GR significantly overlaps with AR targets, impacting prostate cancer pathways.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • The forkhead protein FoxA1 is known as a pioneer factor.
  • FoxA1 depletion causes significant redistribution of androgen receptor (AR) and glucocorticoid receptor (GR) cistromes.

Purpose of the Study:

  • To investigate the novel function of FoxA1 in defining cell-type specificity for AR and GR binding.
  • To explore the interplay between AR and GR in prostate cancer, particularly the role of GR.

Main Methods:

  • ChIP-sequencing to map AR and GR binding sites.
  • Analysis of cis-element enrichment near binding sites.
  • Gene expression analysis to assess transcription programs.

Main Results:

  • FoxA1 dictates cell-type-specific AR binding in LNCaP-1F5 cells and GR binding in VCaP cells.
  • Distinct cis-element compositions are associated with AR and GR binding sites.
  • Significant overlap exists between AR and GR cistromes and transcription programs.
  • GR regulates AR-specific genes and can attenuate AR activity in the presence of androgen.

Conclusions:

  • FoxA1 plays a crucial role beyond pioneering, influencing AR and GR cistrome specificity.
  • GR's extensive overlap with AR targets suggests a significant role in prostate cancer, potentially in castration resistance.
  • Ligand-bound GR acts as a partial antiandrogen, modulating AR-dependent transcription.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...